VistaGen Therapeutics, Inc. (VTGN)
USD 2.32
(-4.53%)
USD 2.32
(-4.53%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 1.06 Million | -227.3 Thousand | 1.1 Million | 1.08 Million | - | - |
| Cost of Revenue | 568 Thousand | 509.8 Thousand | 815.2 Thousand | - | 103.1 Thousand | 91.2 Thousand |
| Gross Profit | 496 Thousand | -737.1 Thousand | 293.7 Thousand | 1.08 Million | -103.1 Thousand | -91.2 Thousand |
| Operating Expenses | 34.08 Million | 58.45 Million | 48.65 Million | 19.02 Million | 19.97 Million | 24.53 Million |
| Selling, General and Administrative Expenses | 14.06 Million | 14.17 Million | 13.24 Million | 6.54 Million | 6.6 Million | 7.43 Million |
| Research and Development Expenses | 20.02 Million | 44.27 Million | 35.4 Million | 12.47 Million | 13.37 Million | 17.09 Million |
| Other Expenses | - | - | - | 600.00 | -827 Thousand | -48.7 Thousand |
| Cost and Expenses | 34.08 Million | 58.96 Million | 48.65 Million | 19.02 Million | 19.97 Million | 24.53 Million |
| Operating Income | -33.02 Million | -59.19 Million | -47.77 Million | -17.93 Million | -20.8 Million | -24.55 Million |
| Interest Expense | - | 23 Thousand | 232 Thousand | 13 Thousand | 15 Thousand | 8000.00 |
| Income Tax Expense | 4000.00 | 5900.00 | 3400.00 | 2600.00 | 2600.00 | 2600.00 |
| Earnings before Tax | -29.35 Million | -59.24 Million | -47.75 Million | -17.93 Million | -20.77 Million | -24.58 Million |
| Net Income | -29.36 Million | -59.24 Million | -47.76 Million | -17.93 Million | -20.77 Million | -24.58 Million |
| Earnings Per Share Basic | -1.52 | -8.51 | -7.24 | -6.25 | -14.21 | -25.83 |
| Earnings Per Share Diluted | -1.52 | -8.51 | -7.24 | -6.25 | -14.21 | -25.83 |
| Weighted Average Shares Outstanding | 19.35 Million | 6.95 Million | 6.59 Million | 2.87 Million | 1.46 Million | 952.08 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 19.35 Million | 6.95 Million | 6.59 Million | 2.87 Million | 1.46 Million | 952.08 Thousand |
| Gross Margin | 0.47 | 3.24 | 0.26 | 1.00 | - | - |
| EBIT Margin | -30.50 | 258.16 | -42.22 | -16.34 | - | - |
| Profit Margin | -27.60 | 260.66 | -43.07 | -16.46 | - | - |
| EBITDA | -32.45 Million | -58.7 Million | -46.94 Million | -17.8 Million | -20.65 Million | -24.46 Million |
| Earnings Before Tax Margin | -31.03 | 260.41 | -43.09 | -16.46 | - | - |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 1.06 Million | 197.3 Thousand | 411.4 Thousand | 277.7 Thousand | 177.6 Thousand | 175.6 Thousand |
| Cost of Revenue | 568 Thousand | 146.5 Thousand | 143.2 Thousand | 140.3 Thousand | 340 Thousand | 153.6 Thousand |
| Gross Profit | 496 Thousand | 50.8 Thousand | 268.2 Thousand | 137.4 Thousand | -162.4 Thousand | 22 Thousand |
| Operating Expenses | 34.08 Million | 11.4 Million | 8.15 Million | 6.91 Million | 6.83 Million | 12.26 Million |
| Selling, General and Administrative Expenses | - | 3.97 Million | 3.61 Million | 3.06 Million | 2.66 Million | 2.95 Million |
| Research and Development Expenses | - | 7.43 Million | 4.53 Million | 3.85 Million | 4.16 Million | 9.3 Million |
| Other Expenses | 312 Thousand | - | - | - | - | 77 Thousand |
| Cost and Expenses | 34.08 Million | 11.55 Million | 8.29 Million | 7.05 Million | 7.17 Million | 12.41 Million |
| Operating Income | -33.02 Million | -11.35 Million | -7.88 Million | -6.78 Million | -6.99 Million | -12.23 Million |
| Interest Expense | - | - | - | - | 6000.00 | 3000.00 |
| Income Tax Expense | 4000.00 | 1500.00 | - | - | 2500.00 | 400.00 |
| Earnings before Tax | -29.35 Million | -9.51 Million | -6.34 Million | -6.58 Million | -6.9 Million | -12.22 Million |
| Net Income | -29.35 Million | -9.52 Million | -6.34 Million | -6.58 Million | -6.9 Million | -12.22 Million |
| Earnings Per Share Basic | - | -0.35 | -0.22 | -0.66 | -0.94 | -1.71 |
| Earnings Per Share Diluted | - | -0.35 | -0.22 | -0.66 | -0.94 | -1.71 |
| Weighted Average Shares Outstanding | 19.35 Million | 27.02 Million | 29.38 Million | 10.04 Million | 7.37 Million | 7.16 Million |
| Weighted Average Shares Outstanding (Diluted) | 19.35 Million | 27.02 Million | 29.38 Million | 10.04 Million | 7.37 Million | 7.16 Million |
| Gross Margin | 0.47 | 0.26 | 0.65 | 0.49 | -0.91 | 0.13 |
| EBIT Margin | - | -56.83 | -18.82 | -23.91 | -37.49 | -68.82 |
| Profit Margin | -27.59 | -48.26 | -15.43 | -23.72 | -38.87 | -69.63 |
| EBITDA | - | -11.21 Million | -7.74 Million | -6.63 Million | -6.65 Million | -12.08 Million |
| Earnings Before Tax Margin | -31.03 | -57.57 | -19.16 | -24.42 | -39.40 | -69.70 |
ONTO
LSPD
AAMC
TTWO
RUSTOMJEE
SAPGF